CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Oral immunotherapydietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03361072
NCT03361072N/ACompleted
CompareCT.gov

The Effect of Per Oral Immunotherapy Treatment in Severe IgE Mediated Milk, Peanut and Egg Allergy in Adults

Helsinki University Central Hospital·interventional·Posted Dec 4, 2017·Updated May 9, 2025

In Brief

A clinical study evaluating Oral immunotherapy for Food Allergy. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The aim is to analyse the results of per oral immunotherapy treatment in severe milk, peanut or egg allergy in adults. This is the second part of the oral immunotherapy study in adults at Skin and Allergy Hospital. The diagnosis of food allergy is verified with positive history, skin prick tests, egg and milk allergen specific IgE (immunoglobulin E) antibodies. In addition, food allergy is verified with an open label (milk allergy) or blind (peanut and egg allergy) allergen specific challenge test. OIT (oral immunotherapy) is performed according to a detailed plan. Lung function parameters are followed before OIT and and a year after OIT.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFood Allergy
CountriesFinland
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedDec 4, 2017
Enrollment StartAug 3, 2017
Primary CompletionMar 11, 2023
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 8.6 years ago

Interventions

Oral immunotherapydietary

Milk, peanut or egg oral immunotherapy